
Yahoo · 14 de sept de 2026
BSX's deal-making push expands its reach into high-growth markets, with Penumbra adding a major thrombectomy opportunity.
Medtronic Public Limited Company
Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients in the United States, Ireland, and internationally. It operates through three segments: The Cardiovascular Portfolio, Neuroscience Portfolio, and Medical Surgical Portfolio. The Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac monitor systems; TYRX products; and remote monitoring and patient-centered software. It also provides aortic valves, surgical valve replacement and repair products, endovascular stent grafts and accessories, and transcatheter pulmonary valves, left atrial appendage exclusion systems, extracorporeal membrane oxygenation (ECMO) systems and percutaneous coronary intervention products, percutaneous angioplasty balloons, and endovenous products. The Neuroscience Portfolio segment offers medical devices and implants, biologic solutions, spinal cord stimulation and brain modulation systems, implantable drug infusion systems, and interventional products, as well as nerve ablation system under the Accurian name. This segment offers its products for spinal surgeons, neurosurgeons, neurologists, pain management specialists, anesthesiologists, orthopedic surgeons, urologists, urogynecologists, and interventional radiologists, as well as ear, nose, and throat specialists, and energy surgical instruments. The Medical Surgical Portfolio segment offers surgical stapling devices, vessel sealing instruments, wound closure and electrosurgery products, AI-powered surgical video and analytics platform, robotic-assisted surgery products, hernia mechanical devices, mesh implants, gynecology products, gastrointestinal and hepatologic diagnostics and therapies, and therapies to treat diseases and conditions, and patient monitoring and airway management products, as well as insulin pumps and consumables, continuous glucose monitoring systems, and sensors. Medtronic plc was founded in 1949 and is headquartered in Galway, Ireland.
Últimos 203 días · 12/11/25 — 14/09/26
+6.00%
Precio
$ 37.220
Var. %
-0,69%
Volumen operado
71
Precio MDT
US$ 94,53
Teórico (precio / ratio)
MDT ÷ 4
US$ 23,63
Sí, existe el CEDEAR de MDT (Medtronic Public Limited Company) en la Bolsa de Comercio de Buenos Aires (BYMA). Su ticker local es MDT.
El ticker del CEDEAR de Medtronic Public Limited Company en Argentina es MDT. La acción subyacente cotiza en NYSE con el símbolo MDT.
El CEDEAR MDT tiene un ratio de 4:1. Eso significa que 4 CEDEARs equivalen a 1 acción de MDT.
El CEDEAR MDT cotiza hoy a $ 37.220 en pesos argentinos, con una variación diaria de -0,69%.
La acción subyacente MDT (Medtronic Public Limited Company) cotiza a US$ 94,53 en su mercado de origen (NYSE).

Yahoo · 14 de sept de 2026
BSX's deal-making push expands its reach into high-growth markets, with Penumbra adding a major thrombectomy opportunity.

Yahoo · 14 de sept de 2026
Intuitive Surgical (ISRG) trades near $370, about 38% below its 52-week high, after growth in its US robotic-surgery procedures slowed. Selling a put pays you n…

ChartMill · 14 de sept de 2026
Wondering what's happening in today's pre-market session? Stay tuned for the latest updates on S&P500 stock movements.
Precio de cierre en pesos argentinos. Fuente: data912.
Cotización
US$ 23,76
vs teórico
+0,54%
Cotización MEP implícita
$ 1.566,5
Cotización
—
vs teórico
—
Cotización Cable implícita
—
El precio teórico del CEDEAR MDT se calcula dividiendo el precio de MDT por el ratio (4). Hoy resulta en US$ 23,63.
En BYMA podés operar MDT en pesos, MDTD en dólar MEP y MDTC en dólar cable. Cada modalidad refleja un tipo de cambio distinto.
En esta página encontrás un gráfico con el precio histórico del CEDEAR MDT en pesos argentinos, con datos de data912.

Yahoo · 14 de sept de 2026
The separation will allow Medtronic to focus on its cardiovascular, neuroscience and surgical portfolios, CEO Geoff Martha said.

Yahoo · 14 de sept de 2026
Medtronic plc (Medtronic; NYSE: MDT) today announced that it has commenced an exchange offer to split off at least 80.1% of the shares of MiniMed Group, Inc. (M…

Yahoo · 14 de sept de 2026
MiniMed (Nasdaq: MMED) announced that it has filed a Form S-4 Registration Statement today with the Securities and Exchange Commission (the "SEC") in connection…
Benzinga · 14 de sept de 2026
MiniMed (NASDAQ:MMED) announced that it has filed a Form S-4 Registration Statement today with the Securities and Exchange Commission (the "SEC") in con…

Yahoo · 13 de sept de 2026
Both Medtronic and Abbott have raised their dividends for nearly half a century, but retirement investors with limited capital can only choose one. The case for…
Noticias vía Finnhub